Oral involvement in primary Sjögren syndrome

Journal of the American Dental Association

Volumn 139, Issue 12, 2008, Pages 1592-1601

  Fox, Philip C ^a   Bowman, Simon J ^b   Segal, Barbara ^c   Vivino, Frederick B ^d   Murukutla, ^e   Choueiri, Karen ^e   Ogale, Sarika ^f   McLean, Lachy ^f  

^a PC Fox Consulting   (Italy)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e Harris Interactive   (United States)

^f GENENTECH INC   (United States)

Author keywords

Dental spending; Oral symptoms; Primary sj gren syndrome; Quality of life

Indexed keywords

EID: 58149242353     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2008.0101     Document Type: Article

References (33)

1. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164(12): 1275-1284.
2. Mathews SA, Kurien BT, Scofield RH. Oral manifestations of Sjögren's syndrome. J Dent Res 2008;87(4):308-318.
3. Dawson LJ, Fox PC, Smith PM. Sjogrens syndrome: the nonapoptotic model of glandular hypofunction. Rheumatology (Oxford) 2006;45(7):792-798.
4. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005;165(20):2337-2344.
5. Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction and quality of life in Sjögren syndrome: a critical oral-systemic connection. JADA 2008;139(3):291-299.
6. Roberts C, Parker GJ, Rose CJ, et al. Glandular function in Sjögren syndrome: assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling-initial experience. Radiology 2008;246(3):845-853.
7. Leung KC, Leung WK, McMillan AS. Supra-gingival microbiota in Sjögren's syndrome. Clin Oral Investig 2007;ll(4):415-423.
8. van den Berg I, Pijpe J, Vissink A. Salivary gland parameters and clinical data related to the underlying disorder in patients with persisting xerostomia. Eur J Oral Sci 2007;115(2):97-102.
9. Leonard G, Flint S. Oral and dental aspects of Sjögren's syndrome. J Ir Dent Assoc 2006;52(3):130-136.
10. Márton K, Boros I, Varga G, et al. Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren's syndrome. Oral Dis 2006;12(5):480-486.
11. Pijpe J, Kalk WW, Bootsma H, Spijkervet FK, Kallenberg CG, Vissink A. Progression of salivary gland dysfunction in patients with Sjogren's syndrome. Ann Rheum Dis 2007;66(1):107-112.
12. Helenius LM, Meurman JH, Helenius I, et al. Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand 2005;63(5):284-293.
13. Pertovaara M, Korpela M, Uusitalo H, et al. Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both). Ann Rheum Dis 1999;58(7):423-427.
14. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000;29(5):296-304.
15. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46(3):741-747.
16. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50(4):1262-1269.
17. García-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002;81(4):270-280.
18. Champey J, Corruble E, Gottenberg JE, et al. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 2006; 55(3):451-457.
19. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61(6):554-558.
20. Bowman SJ, Booth DA, Platts RG; UK Sjögren's Interest Group. Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool. Rheumatology (Oxford) 2004;43(6):758-764.
21. Bowman SJ, Booth DA, Platts RG, Field A, Rostron J; UK Sjögren's Interest Group. Validation of the Sicca Symptoms Inventory for clinical studies of Sjögren's syndrome. J Rheumatol 2003;30(6):1259-1266.
22. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Centre; 1993.
23. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997;13(2):63-74.
24. Radloff LS, The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychological Meas 1977;1:385-401.
25. Shikiar R, Howard K, Yu EB, et al. Validation of LUP-QOL: a lupus-specific measure of health-related quality of life. Poster presented at: European League Against Rheumatism (EULAR) 2006 Annual Congress; June 2006; Amsterdam, Netherlands.
26. Salek S, Compendium of Quality of Life Instruments. Vol. 2.; New York City: Wiley; 1998.
27. Goëb V, Salle V, Duhaut P, et al. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome. Clin Exp Immunol 2007; 148(2):281-287.
28. Locht H, Pelck R, Manthorpe R, Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome. J Rheumatol 2008;35(5):845-849.
29. Cai FZ, Lester S, Lu T, et al. Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study. Arthritis Res Ther 2008; 10(2):R31.
30. Routsias JG, Tzioufas AG. Sjögren's syndrome: study of autoantigens and autoantibodies. Clin Rev Allergy Immunol 2007;32(3):238-251.
31. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ. Xerostomia: evaluation of a symptom with increasing significance. JADA 1985;110(4):519-525.
32. Hochberg MC, Tielsch J, Munoz B, Bandeen-Roche K, West SK, Schein OD. Prevalence of symptoms of dry mouth and their relationship to saliva production in community dwelling elderly: the SEE project. Salisbury Eye Evaluation. J Rheumatol 1998;25(3):486-491.
33. Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. JADA 2003;134(1):61-69.